Functional Interrogation of Non-coding DNA Sequences in leukemia development and drug resistance

Project description

Targeting non-coding DNA for the development of innovative anticancer therapies

Fields of science

• medical and health sciences › clinical medicine › oncology › leukemia
• natural sciences › biological sciences › genetics › genomes
• medical and health sciences › basic medicine › pharmacology and pharmacy › drug resistance

Programme(s)

• H2020-EU.1.1. - EXCELLENT SCIENCE - European Research Council (ERC)

Topic(s)

• ERC-2020-STG - ERC STARTING GRANTS

Call for proposal

ERC-2020-STG
See other projects for this call

Funding Scheme

ERC-STG - Starting Grant

Host institution

ST. ANNA KINDERKREBSFORSCHUNG GMBH

Address

Zimmermannplatz 10
1090 Wien
Austria

Activity type

Research Organisations

EU contribution

€ 1 784 000

Beneficiaries (2)

ST. ANNA KINDERKREBSFORSCHUNG GMBH

Austria

EU contribution

€ 1 784 000

Address

Zimmermannplatz 10
1090 Wien

Activity type

Research Organisations

ST ANNA KINDERKREBSFORSCHUNG VEREIN

Participation ended

Austria

EU contribution

€ 0

Address

Zimmermannplatz 10
1090 Wien

Activity type

Research Organisations